Vanguard Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $132M | Buy |
1,622,033
+21,946
| +1% | +$1.89M | ﹤0.01% | 1741 |
|
|
2025
Q3 | $140M | Sell |
1,600,087
-1,981
| -0.1% | -$177K | ﹤0.01% | 1708 |
|
|
2025
Q2 | $133M | Buy |
1,602,068
+20,962
| +1% | +$1.75M | ﹤0.01% | 1705 |
|
|
2025
Q1 | $133M | Buy |
1,581,106
+989
| +0.1% | +$92K | ﹤0.01% | 1665 |
|
|
2024
Q4 | $146M | Buy |
1,580,117
+1,846
| +0.1% | +$178K | ﹤0.01% | 1686 |
|
|
2024
Q3 | $147M | Buy |
1,578,271
+21,805
| +1% | +$1.89M | ﹤0.01% | 1704 |
|
|
2024
Q2 | $128M | Buy |
1,556,466
+2,632
| +0.2% | +$193K | ﹤0.01% | 1724 |
|
|
2024
Q1 | $103M | Buy |
1,553,834
+4,964
| +0.3% | +$306K | ﹤0.01% | 1848 |
|
|
2023
Q4 | $87.9M | Buy |
1,548,870
+38,303
| +3% | +$2.01M | ﹤0.01% | 1928 |
|
|
2023
Q3 | $82.3M | Buy |
1,510,567
+33,500
| +2% | +$1.99M | ﹤0.01% | 1912 |
|
|
2023
Q2 | $99.4M | Buy |
1,477,067
+7,232
| +0.5% | +$441K | ﹤0.01% | 1854 |
|
|
2023
Q1 | $75.7M | Sell |
1,469,835
-7,707
| -0.5% | -$374K | ﹤0.01% | 1963 |
|
|
2022
Q4 | $68M | Buy |
1,477,542
+32,861
| +2% | +$1.54M | ﹤0.01% | 2012 |
|
|
2022
Q3 | $73.2M | Sell |
1,444,681
-9,122
| -0.6% | -$456K | ﹤0.01% | 1984 |
|
|
2022
Q2 | $66.2M | Buy |
1,453,803
+27,568
| +2% | +$1.23M | ﹤0.01% | 2058 |
|
|
2022
Q1 | $66.3M | Buy |
1,426,235
+130,881
| +10% | +$5.86M | ﹤0.01% | 2160 |
|
|
2021
Q4 | $65.1M | Buy |
1,295,354
+26,907
| +2% | +$1.39M | ﹤0.01% | 2206 |
|
|
2021
Q3 | $67.3M | Buy |
1,268,447
+121,276
| +11% | +$6.83M | ﹤0.01% | 2204 |
|
|
2021
Q2 | $70M | Buy |
1,147,171
+40,828
| +4% | +$2.17M | ﹤0.01% | 2191 |
|
|
2021
Q1 | $54M | Sell |
1,106,343
-10,540
| -0.9% | -$494K | ﹤0.01% | 2270 |
|
|
2020
Q4 | $45.2M | Buy |
1,116,883
+15,096
| +1% | +$540K | ﹤0.01% | 2255 |
|
|
2020
Q3 | $35.8M | Sell |
1,101,787
-150,598
| -12% | -$4.52M | ﹤0.01% | 2179 |
|
|
2020
Q2 | $33.1M | Sell |
1,252,385
-71,522
| -5% | -$1.87M | ﹤0.01% | 2199 |
|
|
2020
Q1 | $33M | Sell |
1,323,907
-44,446
| -3% | -$1.37M | ﹤0.01% | 2052 |
|
|
2019
Q4 | $49.2M | Buy |
1,368,353
+7,831
| +0.6% | +$270K | ﹤0.01% | 2113 |
|
|
2019
Q3 | $46.5M | Buy |
1,360,522
+23,922
| +2% | +$764K | ﹤0.01% | 2107 |
|
|
2019
Q2 | $37.4M | Buy |
1,336,600
+11,508
| +0.9% | +$320K | ﹤0.01% | 2248 |
|
|
2019
Q1 | $41.1M | Buy |
1,325,092
+59,360
| +5% | +$1.58M | ﹤0.01% | 2187 |
|
|
2018
Q4 | $29.9M | Buy |
1,265,732
+56,990
| +5% | +$1.56M | ﹤0.01% | 2263 |
|
|
2018
Q3 | $46.8M | Buy |
1,208,742
+66,427
| +6% | +$2.39M | ﹤0.01% | 2174 |
|
|
2018
Q2 | $38.2M | Buy |
1,142,315
+157,911
| +16% | +$5.62M | ﹤0.01% | 2267 |
|
|
2018
Q1 | $35.7M | Buy |
984,404
+58,338
| +6% | +$2.02M | ﹤0.01% | 2244 |
|
|
2017
Q4 | $29.5M | Buy |
926,066
+51,693
| +6% | +$1.77M | ﹤0.01% | 2327 |
|
|
2017
Q3 | $32.7M | Buy |
874,373
+58,793
| +7% | +$2M | ﹤0.01% | 2265 |
|
|
2017
Q2 | $25.5M | Buy |
815,580
+155,249
| +24% | +$4.48M | ﹤0.01% | 2355 |
|
|
2017
Q1 | $16.3M | Buy |
660,331
+40,448
| +7% | +$950K | ﹤0.01% | 2526 |
|
|
2016
Q4 | $15.7M | Sell |
619,883
-3,440
| -0.6% | -$76.4K | ﹤0.01% | 2534 |
|
|
2016
Q3 | $12.4M | Buy |
623,323
+39,395
| +7% | +$688K | ﹤0.01% | 2584 |
|
|
2016
Q2 | $8.33M | Buy |
583,928
+58,998
| +11% | +$902K | ﹤0.01% | 2731 |
|
|
2016
Q1 | $8.15M | Buy |
524,930
+84,638
| +19% | +$1.21M | ﹤0.01% | 2720 |
|
|
2015
Q4 | $7.59M | Buy |
440,292
+6,824
| +2% | +$98.8K | ﹤0.01% | 2783 |
|
|
2015
Q3 | $5.28M | Buy |
433,468
+13,371
| +3% | +$171K | ﹤0.01% | 2941 |
|
|
2015
Q2 | $5.07M | Buy |
420,097
+28,807
| +7% | +$284K | ﹤0.01% | 3016 |
|
|
2015
Q1 | $3.28M | Buy |
391,290
+39,900
| +11% | +$313K | ﹤0.01% | 3197 |
|
|
2014
Q4 | $2.69M | Buy |
351,390
+8,209
| +2% | +$58.8K | ﹤0.01% | 3174 |
|
|
2014
Q3 | $2.36M | Buy |
343,181
+1,501
| +0.4% | +$11.2K | ﹤0.01% | 3196 |
|
|
2014
Q2 | $2.83M | Buy |
341,680
+42,300
| +14% | +$331K | ﹤0.01% | 3100 |
|
|
2014
Q1 | $2.42M | Buy |
299,380
+1,040
| +0.3% | +$8.32K | ﹤0.01% | 3136 |
|
|
2013
Q4 | $2.39M | Buy |
298,340
+65,452
| +28% | +$506K | ﹤0.01% | 3120 |
|
|
2013
Q3 | $1.56M | Buy |
232,888
+36,804
| +19% | +$249K | ﹤0.01% | 3232 |
|
|
2013
Q2 | $1.28M | Buy |
+196,084
| New | +$1.24M | ﹤0.01% | 3234 |
|
Other funds holding LMAT
CCA
CCM
GCM
CAM
Vanguard Group's LMAT Position: Q4 2025 in Review
Vanguard Group increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q4 2025, buying an estimated $1.89M and bringing the position to 1,622,033 shares worth $132M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.
Vanguard Group first reported a position in LMAT in Q2 2013 and has held it in 51 quarters since. The position peaked at $147M in Q3 2024. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.
- Vanguard Group held 1,622,033 shares of LeMaitre Vascular worth $132M as of Q4 2025.
- Vanguard Group bought 21,946 LeMaitre Vascular shares in Q4 2025, an estimated $1.89M.
- LeMaitre Vascular made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1741 holding.
- Vanguard Group first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's LeMaitre Vascular position peaked at $147M in Q3 2024.
- 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.